Slingshot members are tracking this event:
NDA to be Filed for Odanacatib for Treatment of Osteoporosis in 2016 Pending Long Safety Review
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Sep 02, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Nda Filing, Odanacatib, Osteoporosis, Cardiovascular Safety, Mk-0822